More Island Pharmaceuticals Ltd news
Island Pharmaceuticals LtdASX: ILA

Pause in Trading

Jul 2, 2026 at 10:22 PM EDT · Issued by Island Pharmaceuticals Ltd

Filed with ASX · Jul 2, 2026 at 10:22 PM EDT · 1 page · English

On 6ix: 6ix.com/news/pause-in-trading-1353

Island Pharmaceuticals Ltd on 6ix

Story so far

  • Trading HaltMar 2, 2026

Earlier from Island Pharmaceuticals

  • Singapore Patent Expands Island's ISLA 101 Viral ProtectionJul 1
  • FDA Grants Orphan Designation for Galidesivir in MarburgJun 16
  • Investor Presentation - Asia Dengue SummitJun 15
  • Investor presentationJun 10
  • Island Secures USAMRIID Support for Galidesivir StudyJun 9

Later from Island Pharmaceuticals

  • Galidesivir approved for treatment use in in Ebola epidemicJul 6
  • Investor Presentation - Ebola Clinical ProgramJul 7
  • Texas Biomed SOW accelerates pivotal FDA pathwayJul 12
  • Island boosts Galidesivir supply as Ebola surgesAug 20
  • Pivotal Marburg data secured for Galidesivir FDA pathwayAug 30
All Island Pharmaceuticals news releases↗

Follow Island Pharmaceuticals into a list and get an email when it puts out news.

Follow Island Pharmaceuticals
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer